BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1567159)

  • 1. Antiplasmid activity of phenothiazines, benzo[a]phenothiazines and benz[c]acridines.
    Motohashi N; Sakagami H; Kurihara T; Csuri K; Molnar J
    Anticancer Res; 1992; 12(1):135-9. PubMed ID: 1567159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activity of phenothiazines, benzo[a]phenothiazines and benz[c]acridines.
    Motohashi N; Sakagami H; Kurihara T; Ferenczy L; Csuri K; Molnar J
    Anticancer Res; 1992; 12(4):1207-10. PubMed ID: 1503410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse biological activities displayed by phenothiazines, benzo[a]phenothiazines and benz[c]acridins (review).
    Molnár J; Sakagami H; Motohashi N
    Anticancer Res; 1993; 13(4):1019-25. PubMed ID: 8352520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of anti-Escherichia coli activity in mice by phenothiazines, benzo[a]phenothiazines and benz[c]acridines.
    Motohashi N; Sakagami H; Komatsu N; Fujimaki M; Wada C; Molnar J
    In Vivo; 1992; 6(6):585-8. PubMed ID: 1296806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplasmid and carcinogenic molecular orbitals of benz[c]acridine and related compounds.
    Molnar J; Petofi S; Kurihara T; Sakagami H; Motohashi N
    Anticancer Res; 1993; 13(1):263-6. PubMed ID: 8476222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of DNA fragmentation in human myelogenous leukaemic cell lines by phenothiazine-related compounds.
    Sakagami H; Takahashi H; Yoshida H; Yamamura M; Fukuchi K; Gomi K; Motohashi N; Takeda M
    Anticancer Res; 1995; 15(6B):2533-40. PubMed ID: 8669819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between topological resonance energy of methyl-substituted benz[c]acridines, benzo[a]phenothiazines and chrysenes, and their carcinogenic or antitumor activities.
    Kurihara T; Motohashi N; Pang GL; Higano M; Kiguchi K; Molnár J
    Anticancer Res; 1996; 16(5A):2757-65. PubMed ID: 8917383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulation activity of phenothiazines, benzo[a]phenothiazines and benz[c]acridines.
    Molnar J; Mandi Y; Petri I; Petofi S; Sakagami H; Kurihara T; Motohashi N
    Anticancer Res; 1993; 13(2):439-42. PubMed ID: 8517660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplasmid activity: loss of bacterial resistance to antibiotics.
    Molnár J; Földeák S; Nakamura MJ; Rausch H; Domonkos K; Szabó M
    APMIS Suppl; 1992; 30():24-31. PubMed ID: 1295542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells.
    Molnár J; Hevér A; Fakla I; Fischer J; Ocsovski I; Aszalós A
    Anticancer Res; 1997; 17(1A):481-6. PubMed ID: 9066699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acridines on bacterial plasmid replication and endotoxin.
    Barbe J; Mándi Y; Hevér A; Petri I; Galy JP; Molnár J
    In Vivo; 1996; 10(6):601-6. PubMed ID: 8986470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical productions and pi-spin density by UHF/PM3 method on benz[c]acridines and benzo[a]phenothiazines.
    Kurihara T; Watanabe T; Yoshikawa K; Motohashi N
    Anticancer Res; 1998; 18(1A):429-32. PubMed ID: 9568114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radical intensity and differentiation-inducing activity of benzo[a]phenothiazines and phenothiazines.
    Satoh K; Sakagami H; Kurihara T; Motohashi N
    Anticancer Res; 1997; 17(4A):2465-9. PubMed ID: 9252664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of phenothiazine-related compounds.
    Nagy S; Argyelan G; Molnár J; Kawase M; Motohashi N
    Anticancer Res; 1996; 16(4A):1915-8. PubMed ID: 8712720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between pi-electron distribution and anticancer activity of benzo[a]phenothiazines.
    Motohashi N; Sasaki Y; Wakabayashi Y; Sakagami H; Molnar J; Kurihara T
    Anticancer Res; 1992; 12(5):1423-6. PubMed ID: 1444201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial effect, plasmid curing activity and chemical structure of some tricyclic compounds.
    Molnár J; Mándi Y; Holland IB; Schneider G
    Acta Microbiol Acad Sci Hung; 1977; 24(1):1-6. PubMed ID: 22219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanine-cytosine rich regions of plasmid DNA can be the target in anti-plasmid effect of phenothiazines.
    Miskolci C; Labádi I; Kurihara T; Motohashi N; Molnár J
    Int J Antimicrob Agents; 2000 Apr; 14(3):243-7. PubMed ID: 10773496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.
    Ford JM; Prozialeck WC; Hait WN
    Mol Pharmacol; 1989 Jan; 35(1):105-15. PubMed ID: 2563302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of phenothiazines, benzo[a] phenothiazines, benz[c]acridines and Pentaglobin on endotoxin.
    Molnár J; Mándi Y; Földes J; Földeák S; Molnár M; Motohashi N
    In Vivo; 1995; 9(5):463-8. PubMed ID: 8900924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between tumor (T) antigen expression and substituent effects on benzo [a] phenothiazines.
    Pusztai R; Motohashi N; Párkányi C; Aaron JJ; Rao BK; Molnár J
    Anticancer Res; 1996; 16(5A):2961-4. PubMed ID: 8917413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.